Study of Pharmacokinetics, Pharmacodynamics, Safety, and Immunogenicity of of HZBio1 in Healthy Subjects
Clinical trial NCT04765995 · COMPLETED
Trial details
- NCT number
- NCT04765995
- Sponsor
- Hangzhou Grand Biologic Pharmaceutical, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-03-01
- Primary completion
- 2021-10-31
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.